The neural basis of visual snow syndrome
- Institution
- UNIVERSITY OF MINNESOTA, MN
- Principal investigator
- Michael-Paul Schallmo
- Funding
- $483K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Visual Snow Syndrome (VSS) is a poorly understood neurological condition whose primary symptom is the constant perception of flickering specks, like television static, superimposed on the visual world. VSS can be debilitating, interfering with daily life activities such as reading and driving. The cause of this condition remains unknown, and there are currently no effective treatment options. Our proposal builds on our recent discovery that a method called visual adaptation can temporarily alleviate visual snow symptoms. This exciting revelation gives us a powerful new tool for understanding the neural basis of visual snow. In this proposal, we will test the hypothesis that VSS is caused by excess spontaneous neural activity within visual brain areas. To do so, we will compare behavioral tests of visual perception using adaptation in people with VSS versus normally sighted control participants, as well as non-invasive measurements of neural activity (functional magnetic resonance imaging) and brain chemistry (magnetic resonance spectroscopy). Understanding where and how spontaneous neural activity leads to visual snow percepts will pave the way for new treatment strategies, objective tests, and biomarkers for VSS, which may in turn improve quality of life, diagnosis, and evaluation of treatment efficacy in this disorder.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MINNESOTA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Minnesota73
Development and Translation of an Intracranial Auditory Nerve Implant
Meredith Evelyn Adams · $1.5M · 2018–2027
- NIH · University of Minnesota66
Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy
Colum D Mackinnon · $787K · 2022–2027
- NIH · University of Minnesota64
High-Throughput In Vitro Analyses of Trauma-Induced Tauopathy
Patrick W Alford · $185K · 2023–2026